Sarcoidosis requiring systemic treatment: Why not a steroid-sparing regimen up-front?

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 27, Issue 1, 2010, Pages 3-4

  Sweiss, N ^a   Yeager, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; METHOTREXATE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ANTIINFLAMMATORY ACTIVITY; CHRONIC DRUG ADMINISTRATION; COMBINATION CHEMOTHERAPY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG MEGADOSE; EDITORIAL; HUMAN; PRIORITY JOURNAL; SARCOIDOSIS; STEROID THERAPY; TREATMENT RESPONSE;

DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; GLUCOCORTICOIDS; HUMANS; PREDNISONE; RISK ASSESSMENT; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 77957583315     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. NIH/NHLBI webpage on sarcoidosis, accessed by H. Yeager 5.31.09.
2. Johns CJ, Schonfeld SA, Scott PA, et al. Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications. Ann N Y Acad Sci 1986; 16: 149-73.
3. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
4. Keystone EC. Is a step-down regimen more effective than a step-up regimen in the treatment of rheumatoid arthritis? Nat Clin Pract Rheumatol 2008; 4: 396-7.
5. Saunders SA, Capell HA, Stirling A, et al. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum 2008; 58: 1310-7. (Pubitemid 351705920)
6. Hanauer SB. Crohn's disease: step-up or top-down therapy. Best Prac Res Clin Gastroenterol 2003; 17: 131-7.
7. Peyrin-Biroulet L, Bigard MA, Malesci A, Danese S. Step-up and top-down approaches to the treatment of Crohn's disease: early may already be too late. Gastroenterology 2008; 12: 1420-22.
8. Baughman RP, Costabel U, DuBois RM. Treatment of sarcoidosis. Clin Chest Med 2008; 29: 533-48.
9. Rempe S, Hayden JM, Robbins RA, et al. Tetracyclines and pulmonary inflammation. Endocr Metab Immune Disord Drug Targets 2007; 7: 232-6.
10. Fliser D, Buchholz K, Haller H, et al. Antiinflammatory effects of angiotensin II subtype1 receptor blockade in hypertensive patients with microinflammation. Circulation 2004; 110: 1103-7.
11. Nagai S, Takeuchi M, Morita K, et al. Angiotensin II receptor on BALF macrophages from Japanese patients with active sarcoidosis. Sarcoidosis Vasc Diffuse Lung Did 1999; 16: 67-74. (Pubitemid 29164273)
12. Marshall TG, Marshall FE. New treatments emerge as sarcoidosis yields up its secrets. Clin Med 2003; 2003010001.